Hereditary Ataxia — Improved Coordination and Speech Recovery

Anvar, a 31-year-old man from Tashkent, Uzbekistan, was diagnosed with hereditary spinocerebellar ataxia type 1 (SCA1) — a progressive neurodegenerative condition with a documented family history, including affected first-degree relatives. At the time of consultation, the condition was associated with gait instability, impaired balance, reduced fine motor control, and progressively worsening speech articulation, resulting in increasing limitations in daily functioning and communication.

• •Bone marrow extraction followed by laboratory cultivation of autologous neuroinduced stem cells
• •Systemic intravenous infusion of stem cells and purified exosomes
• •Intrathecal administration for targeted delivery to the central nervous system
• •Personalised neuro-motor rehabilitation plan adapted to disease stage and functional needs
• •Full protocol delivered over two consecutive treatment days

• •Improved balance and coordination, with greater stability during daily movements
• •Normalisation of muscle tone in both upper and lower limbs
• •Increased physical endurance, including easier stair climbing
• •Notably clearer speech, improved vocal control, and more confident articulation
• •Improved self-confidence and social communication reported by patient and family

Anvar continues his individual rehabilitation programme, with ongoing guidance provided remotely by BioCells Medical specialists. Current follow-up indicates stable functional status, and consideration of further treatment stages remains dependent on clinical evolution and functional priorities.

This case illustrates how a personalised regenerative medicine strategy, combined with targeted neuro-motor rehabilitation, may support functional capacity in patients with rare hereditary neurodegenerative conditions such as SCA1. At BioCells Medical, each programme is individually designed and delivered with continuous medical oversight.